Webinar
Clinical Data Requirements Under MDR: A Panel Discussion
Learn More
White Paper
Navigating Dual Regulations: Strategies for IVD Market Approval in China and the EU
Learn More
Webinar
Considerations for Navigating ISO 22442-3 Viral Inactivation Studies
Learn More
Webinar
Comprehensive Guidance On Reusable Medical Device Processing Requirements: Cleaning, Disinfection and Sterilization Validations
Learn More
Webinar
Preclinical Considerations: Testing Regulated Wound Healing Devices
Learn More
Video
NAMSA Corporate Capabilities
Learn More
Webinar
Ex Vivo and In Vitro Tissue Models: Applications Supporting an Early Indication of Therapeutic Outcome
Learn More
Webinar
ISO 10993-17 2023 Update: What You Need to Know
Learn More
Webinar
Infectious Disease Diagnostic Devices: The Move to at Home Testing and Treatment (Panel Discussion)
Learn More
Webinar
The Chemical Characterization Puzzle: Is There a Solution?
Learn More
Webinar
When Innovation Outpaces Standardization – Solutions to Support Novel Wound Care Product Development
Learn More
Webinar
Biofilm Basics and Beyond
Learn More
White Paper
The FDA’s Draft Guidance on AI- and ML-Enabled Device Software Functions
Learn More
Webinar
Telling Your Medical Device’s Story to Regulatory Agencies
Learn More
Webinar
Clinical Trial Site Budgeting – Risk Mitigation or Budget Control?
Learn More
Webinar
A Practical Guide to Writing Summaries of Safety and Clinical Performance
Learn More
Case Study
MedTech Chats: MEGA BIOPHARMA Partners with NAMSA to De-Risk Disruptive Dental Technology
Learn More
White Paper
The Relationship Between Risk Management and Labeling
Learn More
Webinar
Exhaustive Extractions in E&L Studies – Endpoint Determination Challenges, Expectations and Reality
Learn More
Video
NAMSA Lab Equipment and Facilities
Learn More
Literature
NAMSA Brochure Japanese
Learn More
Literature
NAMSA Brochure
Learn More
Video
NAMSA Histology Laboratory
Learn More
White Paper
Achieving EU and U.S. Commercialization Success: The Critical Linkage Between Reimbursement and Regulatory Strategies
Learn More
Literature
NAMSA Start-Up 360: Accelerating IVD Product Development
Learn More
Case Study
Virtual Vascular Company Partners with NAMSA to Accelerate 510(k) Clearance by 30 Percent
Learn More
White Paper
Medical Device Biological Evaluation Reports: Relevance to ISO 10993-Part 1: 2018
Learn More
Literature
Clinical Research Services Brochure
White Paper
Particulates in Preclinical Testing: Understanding the Impact on Overall Device Biological Safety
Learn More
White Paper
Medical Device Reimbursement Strategy: How to Plan for Successful Market Commercialization
Learn More
Guide
NAMSA Guide: EU MDR & IVDR Regulation Tool
Learn More
Case Study
NAMSA APEX Program™ Expedites 510(k) Clearance for Solvay Dental 360™, Delivers 12 Months & $7.5M in Development Savings
Learn More
Literature
Biocompatibility Matrix
Learn More
Literature